STAT News, January 10, 2025: The FDA’s new guidance to Pharma on how to develop weight loss drugs reflects a cultural shift that treats drugs as the first resort instead of the last resort if changing eating habits and exercising doesn’t work.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Beyond Step Counting: Wearable Tech Promises Medical-grade Data
Barron’s, January 8, 2025: Barron’s article from AFP News describes the promise of new wearable medical devices for improving health and the criticisms by NCHR’s Diana Zuckerman and other experts regarding the lack of certainty about their accuracy due to low regulatory standards by the FDA. This makes it difficult to know which products are accurate and which ones aren’t.
Read More »FDA Off-Label Drug Guidance: 3 Things to Know
Law360, January 7, 2025: FDA Final Guidance on promoting off-label uses of approved drugs will increase sales but we explain it misleads doctors and patients about safety and efficacy because unapproved uses of drugs are not proven to be safe or effective.
Read More »Inside The U.S. Effort To Boost The Natural Grass Industry
Forbes, December 22, 2024: This excellent article in Forbes explains how USDA is trying to boost the natural grass industry for its advantages compared to artificial grass and its importance to the economy. NCHR agrees that natural grass is safer than plastic grass and explains why.
Read More »Vivek Ramaswamy’s crusade to change FDA could boost biotech, and himself
The Washington Post, November 25, 2024: This news article quotes NCHR and other experts explaining that Vivek Ramaswamy is a former biotech executive who is very critical of the FDA in ways that reflect his extensive conflicts of interest. If Donald Trump follows Ramaswamy’s advice, Ramaswamy is likely to greatly increase his wealth and patients will be harmed by paying for expensive new medications that do not work.
Read More »